Ir Pharmaceuticals Private Limited
About Ir Pharmaceuticals Private Limited
Data last updated:
Ir Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2016PTC094656. Its GSTIN is 24AAECI3411L1ZS (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Indu Rakesh Kumar Singh and Rakeshkumar Duryodhan Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ground Floor Shop No 3 131/1030 Gujarat Housing Board, Khokhra Mahemdabad Road Khokhra, Ahmedabad, Gujarat, India – 380008.
As per the financials filed for FY 2024, the company reported a revenue of ₹90.86 Lakh, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹1.56 Lakh (net margin 1.7%) and EBITDA of ₹2.48 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 35% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGround Floor Shop No 3 131/1030 Gujarat Housing Board, Khokhra Mahemdabad Road Khokhra, Ahmedabad, Gujarat, India – 380008
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ir Pharmaceuticals Private Limited
The main business activity of Ir Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ir Pharmaceuticals Private Limited FY 2024 filings available
Ir Pharmaceuticals Private Limited reported revenue of ₹90.86 Lakh (up 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ir Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 41% growth in the latest year. EBITDA rose 186% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ir Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.48 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.56 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ir Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ir Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ir Pharmaceuticals Private Limited
Ir Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Skaipher Nutraceutical Limited | ₹91.73 Lakh (FY 2020) | •••• | •••• | 523.0% | •••• | Kolkata, West Bengal, India |
| Trimark Pharmaceuticals Private Limited | ₹91.65 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Hyderabad, Telangana, India |
| Saaggifo Chemicals and Pharmaceuticals Private Limited | ₹91.27 Lakh (FY 2019) | •••• | •••• | -5.0% | •••• | Kolkata, West Bengal, India |
| Monji Vishram Pharmaceuticals Private Limited | ₹91.05 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Mumbai, Maharashtra, India |
| Stanqualis Healthcare Private Limited | ₹90.94 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Delhi, India |
| Ir Pharmaceuticals Private Limited this company | ₹90.86 Lakh (FY 2024) | •••• | •••• | 41.0% | •••• | Ahmedabad, Gujarat, India |
| Homeonest Remedies Private Limited | ₹90.8 Lakh (FY 2025) | •••• | •••• | •••• | Meerut, Uttar Pradesh, India | |
| Unipower Pharmaceuticals Private Limited | ₹90.78 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Delhi, India |
| RSL Bioscience Private Limited | ₹90.44 Lakh (FY 2023) | •••• | •••• | 30.0% | •••• | New Delhi, Delhi, India |
| Spiremed Pharmaceuticals Private Limited | ₹90.38 Lakh (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Vedic Mediflow Device Private Limited | ₹90.33 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Ir Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ir Pharmaceuticals Private Limited
Ir Pharmaceuticals Private Limited is audited by RONAK THAKKAR for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RONAK THAKKAR | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ir Pharmaceuticals Private Limited
Ir Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indu Rakesh Kumar Singh | Director | 09 Dec 2016 | 9 Years 10 Months | Current |
| Rakeshkumar Duryodhan Singh | Director | 09 Dec 2016 | 9 Years 10 Months | Current |
Ownership and Shareholding of Ir Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ir Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2024 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ir Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ir Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ir Pharmaceuticals Private Limited
Ir Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Indu Rakesh Kumar Singh was appointed as Director on 09 Dec 2016.
Credit Ratings, Litigation & Regulatory Alerts for Ir Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ir Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ir Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ir Pharmaceuticals Private Limited
Ir Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECI3411L1ZS | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ir Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ir Pharmaceuticals Private Limited
Ir Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 December 2016 (10+ years old) and is registered under CIN U51909GJ2016PTC094656.
Ir Pharmaceuticals reported revenue of ₹90.86 Lakh for FY 2024 (up 41% YoY).
Ir Pharmaceuticals has 2 current directors:
- Indu Rakesh Kumar Singh - Director
- Rakeshkumar Duryodhan Singh - Director
Ir Pharmaceuticals reported a net profit of ₹1.56 Lakh (net margin 1.7%) and EBITDA of ₹2.48 Lakh (EBITDA margin 2.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ir Pharmaceuticals is 30% over three years and 35% over five years. In the latest year (FY 2024) revenue rose 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ir Pharmaceuticals is 24AAECI3411L1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Ir Pharmaceuticals is U51909GJ2016PTC094656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ir Pharmaceuticals was incorporated on 09 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ir Pharmaceuticals by revenue are Skaipher Nutraceutical Limited, Trimark Pharmaceuticals Private Limited, Saaggifo Chemicals and Pharmaceuticals Private Limited, Monji Vishram Pharmaceuticals Private Limited, Stanqualis Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Indu Rakesh Kumar Singh was appointed as Director on 09 Dec 2016. Rakeshkumar Duryodhan Singh was appointed as Director on 09 Dec 2016.
Yes, Ir Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).